Product Overview

Calkrom Nasal Spray is a pharmaceutical nasal formulation containing Calcitonin (Salmon) Nasal Solution USP. The product is presented in a 6 mL pack containing 60 metered doses and belongs to the osteoporosis and bone-health segment.

Calcitonin-salmon nasal formulations are used in the treatment of postmenopausal osteoporosis. Current prescribing information describes calcitonin-salmon nasal solution as an option for postmenopausal women more than five years after menopause, particularly when alternative treatments are not suitable.

The nasal spray dosage form makes Calkrom a specialized addition to pharmaceutical portfolios focused on bone health, osteoporosis management and related therapeutic segments.

What Is Calkrom Nasal Spray Used For?

Calkrom Nasal Spray is used for the treatment of postmenopausal osteoporosis.

Postmenopausal osteoporosis is a condition associated with reduced bone mass and deterioration of bone tissue, which can increase susceptibility to fractures. Calcitonin-salmon nasal formulations have been studied for their effect on spinal bone mineral density in postmenopausal women with osteoporosis.

The product should be used according to the approved prescribing information and under the direction of a qualified healthcare professional.

Product Details

Particular	Details
Brand Name	Calkrom
Generic / Active Ingredient	Calcitonin (Salmon)
Formulation	Nasal Solution USP
Dosage Form	Nasal Spray
Pack Volume	6 mL
Metered Doses	60
Therapeutic Segment	Osteoporosis / Bone Health
Company	Farlex Pharmaceuticals Pvt. Ltd.

Key Product Highlights

Calcitonin (Salmon) nasal formulation
Nasal spray dosage form
USP-standard formulation
6 mL pack
60 metered doses
Used in the management of postmenopausal osteoporosis
Specialized bone-health product
Suitable for focused pharmaceutical portfolios
Relevant for B2B pharma distribution and marketing

B2B Pharma Portfolio Opportunity

The osteoporosis and bone-health segment represents a specialized area within the pharmaceutical market. Products with focused therapeutic positioning can help pharmaceutical businesses develop a more comprehensive portfolio for healthcare channels serving appropriate patient populations.

Calkrom Nasal Spray provides a Calcitonin (Salmon) nasal formulation that can be considered by PCD pharma franchise companies, pharmaceutical distributors, stockists, super stockists and pharma marketers seeking to expand their osteoporosis and bone-health product range.

Its specialized nasal dosage form also provides portfolio differentiation for businesses developing focused therapeutic offerings.

Why Add Calkrom to Your Pharma Portfolio?

Calkrom combines a specialized active ingredient with a nasal delivery format and a convenient metered-dose presentation.

Portfolio Highlights

Calcitonin (Salmon) formulation
Specialized osteoporosis positioning
Nasal spray delivery system
60 metered-dose presentation
6 mL pack
Suitable for bone-health-focused product portfolios
Relevant for specialized pharmaceutical distribution channels

Packing

6 mL Nasal Spray – 60 Metered Doses

The final commercial packing configuration should be confirmed against the latest approved product specification before purchase, listing or regulatory use.

Ideal B2B Buyers

Calkrom Nasal Spray may be relevant for:

PCD Pharma Franchise Partners
Pharma Distributors
Stockists & Super Stockists
Pharma Marketing Companies
Specialty Pharma Businesses
Institutional Pharmaceutical Suppliers
Bone Health / Osteoporosis Portfolio Owners
International Pharma Buyers, subject to applicable regulatory requirements

Business Enquiry

Looking to add a Calcitonin (Salmon) Nasal Spray to your pharmaceutical portfolio?

Connect with Farlex Pharmaceuticals Pvt. Ltd. for product availability, commercial details, business partnership opportunities and applicable product-range information.

Enquire Now for Product & Business Details.